Despite the catchy name, “Right to Try” only offers False Hope. It fails to give patients any right to access drugs or devices, and allows companies to sell potentially ineffective or harmful investigational products to the public without any legal, medical, or financial protections for patients.
It’s a solution to a problem that doesn’t exist.
We need better treatments for breast cancer and other diseases. But passing federal Right to Try legislation isn’t what will set us on the path toward new treatments that are less toxic, more effective, or more affordable. It’s legislation that puts patient safety at risk and undermines the FDA’s authority to regulate drugs in development.
The Senate already passed the dangerous and misleadingly named drug access bill known as "Right to Try" (The Right to Try Act of 2017, or S.204). A similar bill on the House side is imminent, and stopping it in the House is our last defense.
You can help stop False Hope and protect patient rights by taking action right now. Any version of a Right to Try bill that weakens drug regulation and puts patient safety at risk is a bill that doesn't truly put patients first. Your Representative needs to hear from you now! Email or call today and tell them to vote "No" on Right to Try.
We've made it as easy as possible for you to contact your Representative today. Enter your information in the form (to your right, or below). For emails, please note that all of the information fields are required because many legislators use contact forms with these details. If you choose to call your Representative, you'll receive a call that will provide guidance on what to say and then patch you directly through to them.
Many thanks to our friends at Treatment Action Group (TAG), who are partnering with us on this action.